本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Quoin Pharmaceuticals

16.21
+1.187.85%
盘后16.10-0.1100-0.68%19:56 EST
成交量:19.00万
成交额:306.47万
市值:1,359.98万
市盈率:-0.50
高:17.77
开:15.24
低:14.76
收:15.03
52周最高:48.30
52周最低:5.01
股本:83.90万
流通股本:69.65万
量比:0.05
换手率:27.28%
股息:- -
股息率:- -
每股收益(TTM):-32.5861
每股收益(LYR):-66.9021
净资产收益率:-651.40%
总资产收益率:-99.47%
市净率:-11.20
市盈率(LYR):-0.24

数据加载中...

2023/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals